Self-management support intervention to control cancer pain in the outpatient setting: a randomized controlled trial study protocol

Laura M J Hochstenbach, Annemie M Courtens, Sandra M G Zwakhalen, Maarten van Kleef, Luc P de Witte, Laura M J Hochstenbach, Annemie M Courtens, Sandra M G Zwakhalen, Maarten van Kleef, Luc P de Witte

Abstract

Background: Pain is a prevalent and distressing symptom in patients with cancer, having an enormous impact on functioning and quality of life. Fragmentation of care, inadequate pain communication, and reluctance towards pain medication contribute to difficulties in optimizing outcomes. Integration of patient self-management and professional care by means of healthcare technology provides new opportunities in the outpatient setting.

Methods/design: This study protocol outlines a two-armed multicenter randomized controlled trial that compares a technology based multicomponent self-management support intervention with care as usual and includes an effect, economic and process evaluation. Patients will be recruited consecutively via the outpatient oncology clinics and inpatient oncology wards of one academic hospital and one regional hospital in the south of the Netherlands. Irrespective of the stage of disease, patients are eligible when they are diagnosed with cancer and have uncontrolled moderate to severe cancer (treatment) related pain defined as NRS≥4 for more than two weeks. Randomization (1:1) will assign patients to either the intervention or control group; patients in the intervention group receive self-management support and patients in the control group receive care as usual. The intervention will be delivered by registered nurses specialized in pain and palliative care. Important components include monitoring of pain, adverse effects and medication as well as graphical feedback, education, and nurse support. Effect measurements for both groups will be carried out with questionnaires at baseline (T0), after 4 weeks (T1) and after 12 weeks (T2). Pain intensity and quality of life are the primary outcomes. Secondary outcomes include self-efficacy, knowledge, anxiety, depression and pain medication use. The final questionnaire contains also questions for the economic evaluation that includes both cost-effectiveness and cost-utility analysis. Data for the process evaluation will be gathered continuously over the study period and focus on recruitment, reach, dose delivered and dose received.

Discussion: The proposed study will provide insight into the effectiveness of the self-management support intervention delivered by nurses to outpatients with uncontrolled cancer pain. Study findings will be used to empower patients and health professionals to improve cancer pain control.

Trial registration: NCT02333968 December 29, 2014.

Figures

Fig. 1
Fig. 1
Flowchart of the study design

References

    1. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437–1449. doi: 10.1093/annonc/mdm056.
    1. Schumacher KL, Koresawa S, West C, Hawkins C, Johnson C, Wais E, et al. Putting cancer pain management regimens into practice at home. J Pain Symptom Manage. 2002;23(5):369–382. doi: 10.1016/S0885-3924(02)00385-8.
    1. Oldenmenger WH, Sillevis Smitt PA, van Dooren S, Stoter G, van der Rijt CC. A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: A critical appraisal. Eur J Cancer. 2009;45(8):1370–1380. doi: 10.1016/j.ejca.2009.01.007.
    1. Jacobsen R, Liubarskiene Z, Moldrup C, Christrup L, Sjogren P, Samsanaviciene J. Barriers to cancer pain management: A review of empirical research. Medicina (Kaunas) 2009;45(6):427–433.
    1. Luckett T, Davidson PM, Green A, Boyle F, Stubbs J, Lovell M. Assessment and management of adult cancer pain: A systematic review and synthesis of recent qualitative studies aimed at developing insights for managing barriers and optimizing facilitators within a comprehensive framework of patient care. J Pain Symptom Manage. 2013;46(2):229–253. doi: 10.1016/j.jpainsymman.2012.07.021.
    1. McCorkle R, Ercolano E, Lazenby M, Schulman-Green D, Schilling LS, Lorig K, et al. Self-management: Enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin. 2011;61(1):50–62. doi: 10.3322/caac.20093.
    1. Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26(1):1–7. doi: 10.1207/S15324796ABM2601_01.
    1. Wilde MH, Garvin S. A concept analysis of self-monitoring. J Adv Nurs. 2007;57(3):339–350. doi: 10.1111/j.1365-2648.2006.04089.x.
    1. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288(19):2469–2475. doi: 10.1001/jama.288.19.2469.
    1. Kravitz RL, Tancredi DJ, Grennan T, Kalauokalani D, Street RL, Jr, Slee CK, et al. Cancer Health Empowerment for Living without Pain (Ca-HELP): effects of a tailored education and coaching intervention on pain and impairment. Pain. 2011;152(7):1572–1582. doi: 10.1016/j.pain.2011.02.047.
    1. van Houtum L, Rijken M, Heijmans M, Groenewegen P. Self-management support needs of patients with chronic illness: Do needs for support differ according to the course of illness? Patient Educ Couns. 2013;93(3):626–632. doi: 10.1016/j.pec.2013.08.021.
    1. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002;48(2):177–187. doi: 10.1016/S0738-3991(02)00032-0.
    1. Holman H, Lorig K. Patient self-management: a key to effectiveness and efficiency in care of chronic disease. Public Health Rep. 2004;119(3):239–43. doi: 10.1016/j.phr.2004.04.002.
    1. Vallerand AH, Musto S, Polomano RC. Nursing’s role in cancer pain management. Curr Pain Headache Rep. 2011;15(4):250–262. doi: 10.1007/s11916-011-0203-5.
    1. Schumacher KL, Clark VLP, West CM, Dodd MJ, Rabow MW, Miaskowski C. Pain medication management processes used by oncology outpatients and family caregivers part i: health systems contexts. J Pain Symptom Manage. 2014;48(5):770–783. doi: 10.1016/j.jpainsymman.2013.12.242.
    1. Dickinson R, Hall S, Sinclair JE, Bond C, Murchie P. Using technology to deliver cancer follow-up: a systematic review. BMC Cancer. 2014;14(1):311. doi: 10.1186/1471-2407-14-311.
    1. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23(2):129–138.
    1. Jensen MP. The validity and reliability of pain measures in adults with cancer. J Pain. 2003;4(1):2–21. doi: 10.1054/jpai.2003.1.
    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376. doi: 10.1093/jnci/85.5.365.
    1. Anderson KO, Dowds BN, Pelletz RE, Edwards WT, Peeters-Asdourian C. Development and initial validation of a scale to measure self-efficacy beliefs in patients with chronic pain. Pain. 1995;63(1):77–84. doi: 10.1016/0304-3959(95)00021-J.
    1. de Wit R, van Dam F, Abu-Saad HH, Loonstra S, Zandbelt L, van Buuren A, et al. Empirical comparison of commonly used measures to evaluate pain treatment in cancer patients with chronic pain. J Clin Oncol. 1999;17(4):1280–7.
    1. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77. doi: 10.1016/S0022-3999(01)00296-3.
    1. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27(2):363–370. doi: 10.1017/S0033291796004382.
    1. Saunders RP, Evans MH, Joshi P. Developing a process-evaluation plan for assessing health promotion program implementation: a how-to guide. Health Promot Pract. 2005;6(2):134–147. doi: 10.1177/1524839904273387.
    1. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. JAMA. 1996;276(14):1172–1177. doi: 10.1001/jama.1996.03540140060028.
    1. van den Brink M, van den Hout WB, Stiggelbout AM, Putter H, van de Velde CJ, Kievit J. Self-reports of health-care utilization: diary or questionnaire? Int J Technol Assess Health Care. 2005;21(3):298–304. doi: 10.1017/S0266462305050397.
    1. The EuroQoL Group: EQ-5D-5L User Guide: Basic information on how to use the EQ-5D-5L instrument; 2011 . Accessed 12 Jan 2015
    1. Oostenbrink J, Bouwmans C, Koopmanschap M, Rutten F. Handleiding voor kostenonderzoek. Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. Erasmus MC: Instituut voor Medical Technology Assessment; 2004.
    1. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. Int J Nurs Stud. 2013;50(5):587–592. doi: 10.1016/j.ijnurstu.2012.09.010.
    1. Linnan L, Steckler A. Process Evaluation for Public Health Interventions and Research. San Francisco, California: Jossey-Bass; 2002.
    1. Oakley A, Strange V, Bonell C, Allen E, Stephenson J, Team RS. Process evaluation in randomised controlled trials of complex interventions. BMJ. 2006;332(7538):413–16. doi: 10.1136/bmj.332.7538.413.
    1. Ransom S, Azzarello LM, McMillan SC. Methodological issues in the recruitment of cancer pain patients and their caregivers. Res Nurs Health. 2006;29(3):190–198. doi: 10.1002/nur.20129.
    1. Berger AM, Neumark DE, Chamberlain J. Enhancing recruitment and retention in randomized clinical trials of cancer symptom management. Oncol Nurs Forum. 2007;34(2):E17–E22. doi: 10.1188/07.ONF.E17-E22.
    1. Koller A, Miaskowski C, De Geest S, Opitz O, Spichiger E. Supporting self-management of pain in cancer patients: Methods and lessons learned from a randomized controlled pilot study. Eur J Oncol Nurs. 2013;17(1):1–8. doi: 10.1016/j.ejon.2012.02.006.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir